Trial Profile
A study assessing efficacy and safety of Telmisartan/S-Amlodipine combination in Korean patients with hypertension in a real world practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Amlodipine/telmisartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2016 New trial record
- 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension